These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9367346)

  • 1. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation.
    Myllärniemi M; Calderon L; Lemström K; Buchdunger E; Häyry P
    FASEB J; 1997 Nov; 11(13):1119-26. PubMed ID: 9367346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
    Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells.
    Koyama N; Morisaki N; Saito Y; Yoshida S
    J Biol Chem; 1992 Nov; 267(32):22806-12. PubMed ID: 1331068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
    Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
    Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
    Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB
    Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo.
    Myllärniemi M; Frösen J; Calderón Ramirez LG; Buchdunger E; Lemström K; Häyry P
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):159-68. PubMed ID: 10372232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells.
    Lo HM; Hung CF; Tseng YL; Chen BH; Jian JS; Wu WB
    Biochem Pharmacol; 2007 Jun; 74(1):54-63. PubMed ID: 17449016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid artery.
    Ishii S; Okamoto Y; Katsumata H; Egawa S; Yamanaka D; Fukushima M; Minami S
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):359-66. PubMed ID: 23324994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor.
    Sihvola R; Koskinen P; Myllärniemi M; Loubtchenkov M; Häyry P; Buchdunger E; Lemström K
    Circulation; 1999 May; 99(17):2295-301. PubMed ID: 10226096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor.
    Zempo N; Koyama N; Kenagy RD; Lea HJ; Clowes AW
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):28-33. PubMed ID: 8548422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phloretin Inhibits Platelet-derived Growth Factor-BB-induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury.
    Wang D; Wang Q; Yan G; Qiao Y; Tang C
    J Cardiovasc Pharmacol; 2015 May; 65(5):444-55. PubMed ID: 25945863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth muscle cells.
    Usui T; Morita T; Okada M; Yamawaki H
    Hypertension; 2014 Feb; 63(2):397-403. PubMed ID: 24166750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation.
    Yang X; Thomas DP; Zhang X; Culver BW; Alexander BM; Murdoch WJ; Rao MN; Tulis DA; Ren J; Sreejayan N
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):85-90. PubMed ID: 16239599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib).
    Chen Z; Lee FY; Bhalla KN; Wu J
    Mol Pharmacol; 2006 May; 69(5):1527-33. PubMed ID: 16436588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis.
    Yamasaki Y; Miyoshi K; Oda N; Watanabe M; Miyake H; Chan J; Wang X; Sun L; Tang C; McMahon G; Lipson KE
    Circ Res; 2001 Mar; 88(6):630-6. PubMed ID: 11282898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
    Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
    Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.